Heart disease is the leading cause of death in America, but the mortality it inflicts is not shared equally between sexes, age groups and races. African Americans experience 2-3 times the likelihood of dying from heart disease compared to whites, at any age. For decades, health disparities have been recognized as a source of pathology in cardiovascular medicine. Despite this, many advances in pharmacology and imaging have aided in the detection and treatment of cardiovascular disease. In this session, we examine whether the same forward thinking that has resulted in a decline in heart disease has impacted the pervasive disparities in cardiovascular medicine. Learn how community organizations, providers and startups are improving prevention, diagnosis and access to treatment.